It was a rare opportunity to have the leaders of the International Progressive MS Alliance, including the Executive Committee, Scientific Steering Committee, Industry Forum members and people affected by progressive MS, together in one (large) room to determine the ongoing strategy of the global Alliance.
Three scientific priorities were identified as the major themes that the Alliance will concentrate on in their research strategy;
- Better understand progression
- Develop more responsive outcome measures and shorter, faster clinical trial designs
- Enhance well-being through rehabilitation and symptom management
A significant amount…
da : www.msif.org